A Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK2336805 Alone and With the Co-administration of TMC435 in Healthy Japanese Participants.
Clinical trial NCT02018536 · COMPLETED
Trial details
- NCT number
- NCT02018536
- Sponsor
- Janssen R&D Ireland
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2014-03-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.